Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Basal ganglia amyloid beta accumulation and cognitive dysfunction in Parkinson disease

Christina Ledbetter, Lana Larmeu, Tyler Reekes, James Patterson, Pradeep Garg, Richard Zweig and Elizabeth Disbrow
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1063;
Christina Ledbetter
1Neurosurgery LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lana Larmeu
1Neurosurgery LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Reekes
2Pharmacology, Toxicology and Neuroscience LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Patterson
3Psychiatry LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pradeep Garg
4BioMedical Research Foundation Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Zweig
5Neurology LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Disbrow
5Neurology LSUHSC Shreveport Shreveport LA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1063

Introduction: Cognitive dysfunction is a significant sign of Parkinson disease (PD) and the pathophysiology is not well understood. Deposition of amyloid beta (Aβ) is necessary in the pathology of cognitive impairment in Alzheimer’s disease, and there is accumulating evidence suggesting that Aβ may also play a role in PD. However, findings are mixed. While several studies agree that Aβ deposition affects cognitive function in PD, there are mixed findings about cortical and striatal staging of amyloidosis. Furthermore, while the importance of striatal Aβ deposition and its role in PD associated dementia is well described; the pattern of regional deposition in mild cognitive impairment is understudied. Therefore, we tested the hypothesis that regional amyloidosis was associated with domain specific mild cognitive impairment in PD. Fourteen patients diagnosed with PD ages 54 to 77 received a battery of neuropsychological tests surveying attention, working memory, switching, inhibition, verbal fluency and processing speed. They also underwent 3T magnetic resonance imaging and Positron Emission Tomography (PET) with the Aβ radioligand florbetapir F18 (Avid Radiopharmaceuticals, Philadelphia PA). Aβ was quantified using FreeSurfer’s PetSurfer pipeline which provided 100 regions of segmentation with signal output normalized to the pons. Basal ganglia regions were matched for side of disease onset. Aβ accumulation in basal ganglia and prefrontal cortex (middle and superior frontal gyrus) were correlate with cognitive performance using Pearson’s correlation (p<0.005). Bilateral Aβ deposition in the Putamen was correlated with semantic fluency (ipsilateral R2 = 0.59, p = 0.001; contralateral R2 = 0.45, p = 0.009 (trend)), semantic switch (ipsilateral R2 = 0.59, p = 0.001; contralateral R2 = 0.64, p = 0.001), switch accuracy (ipsilateral R2 = 0.57, p = 0.002; contralateral R2 = 0.59, p = 0.001), and processing speed (ipsilateral R2 = 0.71, p < 0.001; contralateral R2 = 0.69, p < 0.001). Aβ deposition in the contralateral caudate was associated with processing speed (R2 = 0.53, p = 0.003). Aβ measures from cortical regions of interest were not consistently correlated with cognitive function. Our findings support previous work showing that Aβ accumulation in the basal ganglia is significantly associated with global cognitive dysfunction and dementia in PD. We extend previous work by describing the relationship between domain specific deficits and regional deposition. While PD associated cognitive dysfunction is generally associated with disruptions in basal ganglia-thalamocortical circuits as a result of dopamine depletion, our findings suggest even sub-clinical Aβ accumulation is another factor potentially contributing to PD associated cognitive dysfunction. Funding for this project was provided by Avid Radiopharmaceuticals, the Biomedical Research Foundation of North Louisiana, and the LSU Health Sciences Center Shreveport Grant in Aid program.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Basal ganglia amyloid beta accumulation and cognitive dysfunction in Parkinson disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Basal ganglia amyloid beta accumulation and cognitive dysfunction in Parkinson disease
Christina Ledbetter, Lana Larmeu, Tyler Reekes, James Patterson, Pradeep Garg, Richard Zweig, Elizabeth Disbrow
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1063;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Basal ganglia amyloid beta accumulation and cognitive dysfunction in Parkinson disease
Christina Ledbetter, Lana Larmeu, Tyler Reekes, James Patterson, Pradeep Garg, Richard Zweig, Elizabeth Disbrow
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1063;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • An empirical update of left ventricular 3D segmentation algorithm in myocardial perfusion SPECT imaging
  • Two-year change in 18F-sodium fluoride uptake in the aorta of healthy subjects and angina pectoris patients
Show more Poster - PhysicianPharm

Neurology and Psychiatry

  • Examining Long-Term Impact of Grape Consumption on Brain Metabolism in Patients with Mild Decline in Cognition: a Double-Blind Placebo-Controlled Longitudinal Study
  • Longitudinal Clustering Analysis and Prediction of Parkinson’s Disease Progression
  • Amyloid-beta may contribute to the clinical presentation of dementia with Lewy bodies synergistically in the brain.
Show more Neurology and Psychiatry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire